AcelRx Pharmaceuticals (ACRX)

Earnings in 2023 (TTM): -HK$80.5 Million

According to AcelRx Pharmaceuticals 's latest financial reports the company's current earnings are HK$0.65 Million. In 2022 the company made an earning of HK$0.44 Billion, an increase over its 2021 earnings that were of -HK$0.28 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for AcelRx Pharmaceuticals from 2010 to 2023

Annual earnings

Year	Earnings	Change
2023 (TTM)	-HK$80.5 Million	-117.96%
2022	HK$0.44 B	-264.1%
2021	-HK$0.28 Billion	-13.08%
2020	-HK$0.32 Billion	-24.16%
2019	-HK$0.42 Billion	12.92%
2018	-HK$0.37 Billion	-9.7%
2017	-HK$0.41 Billion	20.88%
2016	-HK$0.34 Billion	82.71%
2015	-HK$0.19 Billion	-29.12%
2014	-HK$0.26 Billion	42.38%
2013	-HK$0.19 Billion	-27.33%
2012	-HK$0.26 Billion	66.59%
2011	-HK$0.16 Billion	70.22%
2010	-HK$88.45 Million

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Cara Therapeutics CARA	-HK$0.82 Billion	918.17%	🇺🇸 USA
Recro Pharma REPH	HK$29.28 M	-136.59%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for AcelRx Pharmaceuticals (ACRX)

Earnings in 2023 (TTM): -HK$80.5 Million